Company page

Stoke Therapeutics, Inc.

Stoke Therapeutics, Inc. is a public company traded under the ticker STOK in the American market. With a market capitalization of approximately $1.81 billion, the company focuses on developing innovative therapies for genetic diseases. Their approach aims to enhance protein production to address underlying causes of these conditions.